Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Director comp.
Director departure
Appointed director
|
|
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results|
Docs:
|
"NeuroOne Medical Technologies Corporation Condensed Balance Sheets June 30, 2023 September 30, 2022 Assets Current assets: Cash and cash equivalents $ 3,083,458 $ 8,160,329 Short-term investments — 2,981,010 Accounts receivable — 33,237 Inventory 1,516,527 704,538 Prepaids and other 278,786 296,649 Total current assets 4,878,771 12,175,763 Intangible assets, net 95,156 111,892 Right-of-use asset 197,324 181,355 Property and equipment, net 586,873 353,599 Total assets $ 5,758,124 $ 12,822,609 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 958,811 $ 927,662 Accrued expenses and other liabilities 789,097 715,839 Deferred revenue — 1,455,188 Total current liabilities 1,747,908 3,098,689 Operating lease liability, long term 88,918 119,556 Total liabilities 1,836,82..." |
|
| 07/27/2023 |
8-K
| Asset disposition |
| 05/11/2023 |
8-K
| Quarterly results |
| 03/17/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 01/13/2023 |
8-K
| Other Events Interactive Data |
| 12/22/2022 |
8-K
| Quarterly results |
| 12/16/2022 |
8-K
| Quarterly results |
| 10/25/2022 |
8-K
| Quarterly results |
| 09/14/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/11/2022 |
8-K
| Quarterly results |
| 08/03/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 06/02/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 03/25/2022 |
8-K
| Other Events Interactive Data |
| 02/14/2022 |
8-K
| Quarterly results |
| 02/04/2022 |
8-K
| Quarterly results |
| 12/15/2021 |
8-K
| Quarterly results |
| 10/14/2021 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements... |
| 10/04/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/07/2021 |
8-K
| Quarterly results |
| 08/13/2021 |
8-K
| Quarterly results |
| 06/24/2021 |
8-K
| Quarterly results |
| 06/08/2021 |
8-K
| Quarterly results |
| 05/25/2021 |
8-K
| Quarterly results |
| 03/31/2021 |
8-K
| Quarterly results |
| 02/23/2021 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/15/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Form of Warrant",
"Form of Purchase Agreement",
"NeuroOne Medical Technologies Corporation Announces Private Placement Eden Prairie, MN – January 12, 2021 – NeuroOne Medical Technologies Corporation , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it has entered into a definitive purchase agreement for the sale of 12,500,000 shares of its common stock and corresponding warrants to purchase 12,500,000 shares of its common stock to certain investors in a private placement. Each share of common stock and corresponding warrant is being sold at an aggregate purchase price of $1.00 for anticipated gross proceeds of $12,500,000. The proposed offering is anticipated to close on or about January 14, 2021, subject to the satisfaction of c...",
"SOURCE:" |
|
| 01/07/2021 |
8-K
| Quarterly results |
| 10/06/2020 |
8-K
| Quarterly results |
| 09/03/2020 |
8-K
| Unregistered Sales of Equity Securities |
| 08/03/2020 |
8-K
| Quarterly results |
| 07/28/2020 |
8-K
| Quarterly results |
|
|
|